Advancing Veterans Brain Health
We invite the best & the brightest to share their innovative ideas to accelerate translation of basic science to diagnostics, treatments, and cures.
We are life science researchers, clinicians, engineers, computational modelers, and patient advocates forging a unique cooperative alliance to transform our understanding of Veterans’ Brain Diseases.
We are adopting state-of-the-art technologies from genomics to biosensors to predictive computer simulations of disease in order to accelerate the discovery of new treatments and cures.
News
Funding Opportunity Announcement by the National Institutes of Health Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms (R01)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the NIH released an FOA on March 7, 2017. This funding opportunity, titled “Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms,” encourages Research Project Grant (R01) applications that will further the development, validation and/or application of animal models for…
April 18, 2017
Events
RAPID-Dx Consensus Conference – May 3-4, 2017 in Washington, D.C.
This Consensus Conference co-hosted by Cohen Veterans Bioscience and the National Institute of Alcohol Abuse and Alcoholism, will convene clinical, research, regulatory, drug & device development and statistical experts to discuss the advancement of biomarker qualification & diagnostic development and device qualification for trauma-related brain disorders and co-morbid conditions using a Case Study approach.
April 13, 2017
Webinars
The Treatment of PTSD and the Warrior Care Network
Wednesday, April 19, 2017, at 12 pm ET
In this webinar, Dr. Barbara Rothbaum, who leads the Emory Veterans Program, will discuss post-traumatic stress disorder (PTSD) and its treatment both in general and within the Warrior Care Network.
April 4, 2017
